Data is not available at this time.
Alpha MOS S.A. operates in the sensory analysis solutions market, specializing in advanced hardware and software for aroma, taste, and visual product evaluation. The company's flagship products include HERACLES Neo, an electronic nose for aroma analysis, ASTREE for taste profiling, and IRIS for visual inspection, complemented by its AlphaSoft data management platform. Serving industries such as beverages, dairy, flavors, and packaging, Alpha MOS targets quality control and R&D applications with its proprietary technology. Positioned as a niche player in analytical instrumentation, the company competes by offering integrated sensory analysis tools that combine gas chromatography, electronic tongue technology, and high-resolution imaging. Its solutions cater to manufacturers seeking objective, repeatable sensory data to optimize product formulations and ensure consistency. While the market for electronic sensory analysis remains specialized, Alpha MOS's focus on multi-modal systems differentiates it from single-sensor competitors.
In FY2020, Alpha MOS reported revenue of €3.6 million, accompanied by a net loss of €3.8 million, reflecting operational challenges and R&D investments. The negative operating cash flow of €784,000 and capital expenditures of €439,000 indicate ongoing investment in product development despite financial strain. The diluted EPS of -€0.35 underscores profitability pressures in this growth phase.
The company's negative earnings and cash flow position highlight significant capital consumption, with limited near-term earnings power. The capital-intensive nature of its analytical instrumentation business requires sustained investment in technology, while market adoption of its solutions remains gradual. The absence of positive operating leverage suggests the business model has yet to reach critical scale.
Alpha MOS maintained €984,000 in cash against €2.9 million of total debt at FY2020-end, indicating constrained liquidity. The debt-heavy capital structure, combined with persistent operating losses, raises concerns about financial sustainability without additional funding. The balance sheet shows limited capacity to absorb further losses or fund aggressive expansion.
With no dividend payments and negative profitability, Alpha MOS appears focused on reinvestment for growth. However, FY2020 results show contracting revenue and widening losses, suggesting challenges in scaling operations. The company's growth trajectory depends on broader adoption of electronic sensory analysis in target industries and potential technological breakthroughs.
The negative beta of -1.35 implies counter-cyclical trading behavior relative to the broader market, though the illiquid nature of the stock may distort this measure. With no positive earnings and limited revenue scale, traditional valuation metrics are inapplicable, leaving the stock price driven by long-term technology potential rather than current fundamentals.
Alpha MOS's proprietary sensory analysis technology provides differentiation in a specialized market, but commercialization challenges persist. The outlook depends on securing additional funding, demonstrating product efficacy at scale, and expanding into adjacent applications. Success requires balancing R&D innovation with cost discipline to achieve sustainable operations in this capital-intensive niche.
Company description, financial data from disclosed FY2020 results
show cash flow forecast
| Fiscal year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |